NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Unilife Corporation (NASDAQ:UNIS) resulting from allegations that Unilife may have issued materially misleading business information to the investing public.
On May 8, 2016, Unilife announced it would postpone its earnings conference call, scheduled for the following day, due to “the discovery by the Company’s current management team of violations of Company policies and procedures and possible violations of law and regulation by the Company’s former Chief Executive Officer and by the former Chairman of the Company’s Board of Directors who resigned in 2015.” On this news, Unilife stock fell $0.15, or 29%, from its previous closing to close at $0.36 on May 9, 2016.
On May 23, 2016, post-market, Unilife announced receipt of a letter from NASDAQ, notifying the Company that it is no longer in compliance with NASDAQ listing requirements. On this news, Unilife stock fell $0.31, or 10%, from its previous closing price to close at $2.64 on May 24, 2016.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Unilife investors. If you purchased shares of Unilife on or before May 23, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-901.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.